11/12/2024 – AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET Download PDF Post navigationPreviousPrevious post:AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell diseaseNextNext post:AB Science webcast of December 16, 2024Related PostsSummary of the webcast held on January 28, 2025January 29, 2025Summary of the webcast held on December 16, 2024December 17, 2024AB Science webcast of December 16, 2024December 16, 2024AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell diseaseOctober 28, 2024AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALSOctober 17, 2024Revenues for the first half of 2024 and update on AB Science’s activitiesOctober 10, 2024
AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell diseaseOctober 28, 2024
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALSOctober 17, 2024
